Meyka Pro banner
BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BWAY●NASDAQ
HealthcareMedical - Specialties
$13.20
$0.28(2.08%)
U.S. Market opens in 14h 18m

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap517.7M
P/E Ratio28.80
EPS (TTM)$0.39
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$14.28
3 Months$15.38
1 Year Target$20.88

BWAY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BrainsWay Ltd. (NASDAQ: BWAY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BrainsWay Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BWAY on the NASDAQ shows an RSI of 36.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.88 for the NASDAQ listing.

Key metrics behind BrainsWay Ltd.'s NASDAQ-traded stock include a P/E ratio of 28.80 and a market capitalization of 517.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BWAY on the NASDAQ.

Price Performance (NASDAQ: BWAY)

1-Day Change
-2.08%
5-Day Change
-0.08%
1-Month Change
-7.69%
3-Month Change
-14.89%
6-Month Change
3.45%
Year-to-Date (YTD) Change
38.80%
1-Year Change
75.07%
3-Year Change
553.47%
5-Year Change
227.54%
All-Time (Max) Change
137.84%

Contact Information

972 2 582 4030
16 Hartum St, Jerusalem, JM, 9777516

Company Facts

1,290 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions